Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thiamine transporter 1 (SLC19A2) is a transmembrane protein responsible for transporting thiamine (vitamin B1) into cells. It plays a crucial role in cellular metabolism and energy production. Mutations in SLC19A2 can lead to Thiamine-responsive megaloblastic anemia syndrome (TRMA), characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness.
High-dose thiamine can bypass defective transporters via passive diffusion, partially restoring thiamine levels in cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiamine transporter 1.